المؤلفون: A. K. Guseva, A. V. Okhlobystin, А. К. Гусева, А. В. Охлобыстин

المصدر: The Russian Archives of Internal Medicine; Том 14, № 2 (2024); 96-107 ; Архивъ внутренней медицины; Том 14, № 2 (2024); 96-107 ; 2411-6564 ; 2226-6704

مصطلحات موضوعية: аутоиммунный панкреатит, primary sclerosing cholangitis, cholangiocarcinoma, immunoglobulin IgG 4, autoimmune pancreatitis, первичный склерозирующий холангит, холангиокарцинома, иммуноглобулин IgG 4

وصف الملف: application/pdf

العلاقة: https://www.medarhive.ru/jour/article/view/1748/1304Test; Drazilova S., Veseliny E., Lenartova P.D., et al. IgG4-Related Sclerosing Cholangitis: Rarely Diagnosed, but not a Rare Disease. Can J Gastroenterol Hepatol. 2021; 2021: 1959832. doi:10.1155/2021/1959832.; Kamisawa T., Zen Y., Pillai S., et al. IgG4-related disease. The Lancet 2015; 385: 1460–1471. doi:10.1016/S0140-6736(14)60720-0.; Löhr J.M., Beuers U., Vujasinovic M., et al. European guideline on IgG4-related digestive disease — UEG and SGF evidence-based recommendations. United European Gastroenterol J. 2020 Jul; 8(6): 637-666. doi:10.1177/2050640620934911.; Roos E., Hubers L.M., Coelen R.J. S., et al. IgG4-Associated Cholangitis in Patients Resected for Presumed Perihilar Cholangiocarcinoma: A 30-Year Tertiary Care Experience. American Journal of Gastroenterology 2018; 113: 765–772. doi:10.1038/s41395-018-0036-5.; Kurita Y., Fujita Y., Sekino Y., et al. IgG4-related sclerosing cholangitis may be a risk factor for cancer. J Hepatobiliary Pancreat Sci 2021; 28: 524–532. doi:10.1002/jhbp.957.; Kubota K., Kato S., Uchiyama T., et al. Discrimination between sclerosing cholangitis-associated autoimmune pancreatitis and primary sclerosing cholangitis, cancer using intraductal ultrasonography. Digestive Endoscopy. 2011; 23: 10–16. doi:10.1111/j.1443-1661.2010.01039.x.; Huggett M.T., Culver E.L., Kumar M., et al. Type 1 autoimmune pancreatitis and IgG4-related sclerosing cholangitis is associated with extrapancreatic organ failure, malignancy, and mortality in a prospective UK cohort. Am J Gastroenterol 2014; 109: 1675–1683. doi:10.1038/ajg.2014.223.; Khosroshahi A., Wallace Z.S., Crowe J.L., et al. International consensus guidance statement on the management and treatment of IgG4- related disease. Arthritis and Rheumatology 2015; 67: 1688–1699. doi:10.1002/art.39132.; Kamisawa T., Nakazawa T., Tazuma S., et al. Clinical practice guidelines for IgG4-related sclerosing cholangitis. J Hepatobiliary Pancreat Sci 2019;26:9–42. doi:10.1002/jhbp.596.; Xiao J., Xu P., Li B., et al. Analysis of clinical characteristics and treatment of immunoglobulin G4-associated cholangitis. Medicine (United States) 2018; 97. doi:10.1097/MD.0000000000009767.; Tanaka A., Tazuma S., Okazaki K., et al. Clinical Features, Response to Treatment, and Outcomes of IgG4-Related Sclerosing Cholangitis. Clinical Gastroenterology and Hepatology 2017; 15: 920-926.e3. doi:10.1016/j.cgh.2016.12.038.; Kersten R., Trampert D.C., Herta T., et al. IgG4-related cholangitis — a mimicker of fibrosing and malignant cholangiopathies. J Hepatol. 2023;79(6):1502-1523. doi:10.1016/j.jhep.2023.08.005.; Terao C., Ota M., Iwasaki T., et al. IgG4-related disease in the Japanese population: a genome-wide association study. Lancet Rheumatol 2019; 1: e14–22. doi:10.1016/S2665-9913(19)30006-2.; Perugino C.A., AlSalem S.B., Mattoo H., et al. Identification of galectin-3 as an autoantigen in patients with IgG4 -related disease. Journal of Allergy and Clinical Immunology 2019; 143: 736-745.e6. doi:10.1016/j.jaci.2018.05.011.; Shiokawa M., Kodama Y., Sekiguchi K., et al. Laminin 511 is a target antigen in autoimmune pancreatitis. Sci Transl Med. 2018; 10(453): eaaq0997. doi:10.1126/scitranslmed.aaq0997.; Du H., Shi L., Chen P., et al. Prohibitin is involved in patients with IgG4 related disease. PLoS One. 2015; 10(5): e0125331. doi:10.1371/journal.pone.0125331.; Hubers L.M., Vos H., Schuurman A.R., et al. Annexin A11 is targeted by IgG4 and IgG1 autoantibodies in IgG4-related disease. Gut. 2018; 67: 728–735. doi:10.1136/gutjnl-2017-314548.; Liu Q., Li B., Li Y., et al. Altered faecal microbiome and metabolome in IgG4-related sclerosing cholangitis and primary sclerosing cholangitis. Gut. 2022; 71: 899–909. doi:10.1136/gutjnl-2020-323565; Hubers L.M., Schuurman A.R., Buijs J., et al. Blue-collar work is a risk factor for developing IgG4-related disease of the biliary tract and pancreas. JHEP Reports. 2021; 3(6): 100385 doi:10.1016/j.jhepr.2021.100385.; Wallace Z.S., Naden R.P., Chari S., et al. The 2019 American College of Rheumatology/European League against Rheumatism classification criteria for IgG4-related disease. Ann Rheum Dis. 2020; 79: 77–87. doi:10.1136/annrheumdis-2019-216561.; Moon S.H., Kim M.H., Lee J.K., et al. Development of a scoring system for differentiating IgG4-related sclerosing cholangitis from primary sclerosing cholangitis. J Gastroenterol. 2017; 52: 483–493. doi.org/10.1007/s00535-016-1246-5.; Ohara H., Nakazawa T., Kawa S., et al. Establishment of a serum IgG4 cut-off value for the differential diagnosis of IgG4-related sclerosing cholangitis: A Japanese cohort. Journal of Gastroenterology and Hepatology (Australia). 2013; 28: 1247–1251. doi:10.1111/jgh.12248.; Madhusudhan K.S., Das P., Gunjan D., Srivastava D.N., Garg P.K. IgG4-Related sclerosing cholangitis: A clinical and imaging review. American Journal of Roentgenology. 2019; 213: 1221–1231. doi:10.2214/AJR.19.21519.; Löhr J.M., Vujasinovic M., Rosendahl J., et al. IgG4-related diseases of the digestive tract. Nat Rev Gastroenterol Hepatol. 2022; 9(3): 185-197. doi:10.1038/s41575-021-00529-y.; Culver E.L., Sadler R., Simpson D., et al. Elevated serum IgG4 levels in diagnosis, treatment response, organ involvement, and relapse in a prospective IgG4-related disease UK cohort. American Journal of Gastroenterology. 2016; 111: 733–743. doi:10.1038/ajg.2016.40.; Boonstra K., Culver E.L., de Buy Wenniger L.M., et al. Serum immunoglobulin G4 and immunoglobulin G1 for distinguishing immunoglobulin G4-associated cholangitis from primary sclerosing cholangitis. Hepatology. 2014; 59: 1954–1963. doi:10.1002/hep.26977.; Manganis C.D., Chapman R.W., Culver EL. Review of primary sclerosing cholangitis with increased IgG4 levels. World J Gastroenterol. 2020; 26: 3126–3144. doi:10.3748/wjg.v26.i23.3126.; Nasser R., Gilshtein H., Mansour S., et al. Isolated Type Immunoglobulin G4 Sclerosing Cholangitis: The Misdiagnosed Cholangiocarcinoma. J Clin Med Res. 2021; 13: 75–81. doi:10.14740/jocmr4428.; Tan L., Guan X., Zeng T., et al. The significance of serum IgG4 and CA19-9, autoantibodies in diagnosis and differential diagnosis of IgG4-related sclerosing cholangitis. Scand J Gastroenterol. 2018; 53: 206–211. doi:10.1080/00365521.2017.1416159.; Navaneethan U., Gutierrez N.G., Jegadeesan R., et al. IgG4 levels in bile for distinguishing IgG4-associated cholangiopathy from other biliary disorders: A single blinded pilot study. Clin Endosc. 2014; 47: 555–559. doi:10.5946/ce.2014.47.6.555.; Vujasinovic M., Maier P., Maetzel H., et al. Immunoglobulin G subtypes-1 and 2 differentiate immunoglobulin G4-associated sclerosing cholangitis from primary sclerosing cholangitis. United European Gastroenterol J. 2020; 8: 584–593. doi:10.1177/2050640620916027.; Wang W., Li Y., Feng H. The Significance of Serum IgG4/IgG and IgG4/IgG1 Ratio in the Diagnosis Value of IgG4-Related Diseases. Discov Med. 2023; 35(177): 476-482. doi:10.24976/Discov.Med.202335177.48; Hirano K., Kawabe T., Yamamoto N., et al. Serum IgG4 concentrations in pancreatic and biliary diseases. Clinica Chimica Acta. 2006; 367: 181–184. doi:10.1016/j.cca.2005.11.031.; Nakazawa T., Naitoh I., Hayashi K., et al. Diagnostic criteria for IgG4-related sclerosing cholangitis based on cholangiographic classification. J Gastroenterol. 2012; 47: 79–87. doi:10.1007/s00535-011-0465-z.; Oseini A.M., Chaiteerakij R., Shire A.M., et al. Utility of serum immunoglobulin G4 in distinguishing immunoglobulin G4-associated cholangitis from cholangiocarcinoma. Hepatology. 2011; 54: 940–948. doi:10.1002/hep.24487.; Nakazawa T, Ohara H, Sano H, et al. Cholangiography can discriminate sclerosing cholangitis with autoimmune pancreatitis from primary sclerosing cholangitis. Gastrointest Endosc. 2004; 60(6): 937-944. doi:10.1016/s0016-5107(04)02229-1; Hirano K., Tada M., Isayama H, et al. Endoscopic evaluation of factors contributing to intrapancreatic biliary stricture in autoimmune pancreatitis. Gastrointest Endosc. 2010; 71: 85–90. doi:10.1016/j.gie.2009.08.008.; Nakazawa T., Ikeda Y., Kawaguchi Y., et al. Isolated intrapancreatic IgG4-related sclerosing cholangitis. World J Gastroenterol. 2015; 21: 1334–1343. doi:10.3748/wjg.v21.i4.1334.; Gochanour E., Jayasekera C., Kowdley K. Primary Sclerosing Cholangitis: Epidemiology, Genetics, Diagnosis, and Current Management. Clin Liver Dis (Hoboken). 2020; 15: 125–128. doi:10.1002/cld.902.; Banales J.M., Marin J.J. G., Lamarca A., et al. Cholangiocarcinoma 2020: the next horizon in mechanisms and management. Nat Rev Gastroenterol Hepatol. 2020; 17: 557–588. doi:10.1038/s41575-020-0310-z.; Bowlus C.L., Arrivé L., Bergquist A., et al. AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma. Hepatology. 2023; 77: 659–702. doi:10.1002/hep.32771.; Tasch J.J., Dube N. An unusual presentation of advanced intrahepatic cholangiocarcinoma: When biopsy results fail. American Journal of Case Reports. 2018; 19: 35–40. doi:10.12659/AJCR.906165.; Invernizzi F., Cilla M., Trapani S., et al. Gender and Autoimmune Liver Diseases: Relevant Aspects in Clinical Practice. J Pers. Med. 2022; 12(6): 925. doi:10.3390/jpm12060925.; Van Dyke A.L., Shiels M.S., Jones G.S., et al. Biliary tract cancer incidence and trends in the United States by demographic group, 1999-2013. Cancer. 2019; 125: 1489–1498. doi:10.1002/cncr.31942.; Chazouilleres O., Beuers U., Bergquist A., et al. EASL Clinical Practice Guidelines on sclerosing cholangitis. J Hepatol. 2022; 77: 761–806. doi:10.1016/j.jhep.2022.05.011.; Brindley P.J., Bachini M., Ilyas S.I., et al. Cholangiocarcinoma. Nat Rev Dis Primers. 2021; 7(1): 65. doi:10.1038/s41572-021-00300-2.; Lee H.E., Zhang L. Immunoglobulin G4-related hepatobiliary disease. Semin Diagn Pathol. 2019; 36: 423–433. doi:10.1053/j.semdp.2019.07.007.; Kimura Y., Harada K., Nakanuma Y. Pathologic significance of immunoglobulin G4-positive plasma cells in extrahepatic cholangiocarcinoma. Hum Pathol. 2012; 43: 2149–2156. doi:10.1016/j.humpath.2012.03.001.; Tokala A., Khalili K., Menezes R., et al. Comparative MRI analysis of morphologic patterns of bile duct disease in IgG4-related systemic disease versus primary sclerosing cholangitis. American Journal of Roentgenology. 2014; 202: 536–543. doi:10.2214/AJR.12.10360.; Naitoh I., Nakazawa T., Ohara H., et al. Endoscopic transpapillary intraductal ultrasonography and biopsy in the diagnosis of IgG4-related sclerosing cholangitis. J Gastroenterol. 2009; 44: 1147–1155. doi:10.1007/s00535-009-0108-9.; Yata M., Suzuki K., Furuhashi N., et al. Comparison of the multidetector-row computed tomography findings of IgG4-related sclerosing cholangitis and extrahepatic cholangiocarcinoma. Clin Radiol. 2016; 71: 203–210. doi:10.1016/j.crad.2015.10.024.; Kim J.H., Byun J.H., Kim S.Y., et al. Sclerosing cholangitis with autoimmune pancreatitis versus primary sclerosing cholangitis: Comparison on endoscopic retrograde cholangiography, MR cholangiography, CT, and MRI. Acta Radiol. 2013; 54: 601–607. doi:10.1177/0284185113481018.; de Vries E., Tielbeke F., Hubers L., et al. IgG4/IgG RNA ratio does not accurately discriminate IgG4-related disease from pancreatobiliary cancer. JHEP Reports. 2020; 2(4): 100116. doi:10.1016/j.jhepr.2020.100116.; Naitoh I., Nakazawa T., Hayashi K., et al. Comparison of intraductal ultrasonography findings between primary sclerosing cholangitis and IgG4-related sclerosing cholangitis. Journal of Gastroenterology and Hepatology (Australia). 2015; 30: 1104–1109. doi:10.1111/jgh.12894.; Deshpande V., Zen Y., Chan J.K. C., et al. Consensus statement on the pathology of IgG4-related disease. Modern Pathology. 2012; 25: 1181–1192. doi:10.1038/modpathol.2012.72.; Cortazar F.B., Stone J.H. IgG4-related disease and the kidney. Nat Rev Nephrol. 2015; 11: 599–609. doi:10.1038/nrneph.2015.95.; Detlefsen S., Klöppel G. IgG4-related disease: with emphasis on the biopsy diagnosis of autoimmune pancreatitis and sclerosing cholangitis. Virchows Archiv. 2018; 472: 545–556. doi:10.1007/s00428-017-2275-z.; Naitoh I., Zen Y., Nakazawa T., et al. Small bile duct involvement in IgG4-related sclerosing cholangitis: Liver biopsy and cholangiography correlation. J Gastroenterol. 2011; 46: 269–276. doi:10.1007/s00535-010-0319-0.; Kawakami H., Zen Y., Kuwatani M., et al. IgG4-related sclerosing cholangitis and autoimmune pancreatitis: Histological assessment of biopsies from Vater’s ampulla and the bile duct. Journal of Gastroenterology and Hepatology (Australia). 2010; 25: 1648–1655. doi:10.1111/j.1440-1746.2010.06346.x.; Wu Q., Chang J., Chen H., et al. Efficacy between high and medium doses of glucocorticoid therapy in remission induction of IgG4-related diseases: a preliminary randomized controlled trial. Int J Rheum Dis. 2017; 20: 639–646. doi:10.1111/1756-185X.13088.; Inoue D., Yoshida K., Yoneda N., et al. IgG4-related disease: Dataset of 235 consecutive patients. Medicine (United States). 2015; 94(15): e680. doi:10.1097/MD.0000000000000680.; Kubota K., Kamisawa T., Nakazawa T., et al. Reducing relapse through maintenance steroid treatment can decrease the cancer risk in patients with IgG4-sclerosing cholangitis: Based on a Japanese nationwide study. Journal of Gastroenterology and Hepatology (Australia) 2023; 38: 556–564. doi:10.1111/jgh.16066.; Fernández-Codina A., Orozco-Gálvez O., Martínez-Valle F. Therapeutic Options in IgG4-Related Disease. Curr Treatm Opt Rheumatol. 2020; 6: 191–204. doi:10.1007/s40674-020-00147-w.; Yunyun F., Yu C., Panpan Z., et al. Efficacy of Cyclophosphamide treatment for immunoglobulin G4-related disease with addition of glucocorticoids. Sci Rep. 2017; 7(1): 6195. doi:10.1038/s41598-017-06520-5.; Yunyun F., Yu P., Panpan Z., et al. Efficacy and safety of low dose Mycophenolate mofetil treatment for immunoglobulin G4-related disease: A randomized clinical trial. Rheumatology (United Kingdom). 2019; 58: 52–60. doi:10.1093/rheumatology/key227.; Luo X., Peng Y., Zhang P., et al. Comparison of the Effects of Cyclophosphamide and Mycophenolate Mofetil Treatment Against Immunoglobulin G4-Related Disease: A Retrospective Cohort Study. Front Med (Lausanne). 2020; 7: 253. doi:10.3389/fmed.2020.00253.; Lanzillotta M., Della-Torre E., Wallace Z.S., et al. Efficacy and safety of rituximab for IgG4-related pancreato-biliary disease: A systematic review and meta-analysis. Pancreatology. 2021; 21: 1395–13401. doi:10.1016/j.pan.2021.06.009.; Patel U., Saxena A., Patel D., et al. Therapeutic Uses of Rituximab and Clinical Features in Immunoglobulin G4-Related Disease: A Systematic Review. Cureus. 2023;15(9):e45044. doi:10.7759/cureus.45044.; Miyazawa M., Takatori H., Kawaguchi K., et al. Management of biliary stricture in patients with IgG4-related sclerosing cholangitis. PLoS One. 2020;15(4), e0232089 15. doi: 0.1371/journal.pone.0232089.; Kuraishi Y., Muraki T., Ashihara N., et al. Validity and safety of endoscopic biliary stenting for biliary stricture associated with IgG4-related pancreatobiliary disease during steroid therapy. Endosc Int Open. 2019;07:E1410–418. doi:10.1055/a-0966-8494.; Brito-Zerón P., Kostov B., Bosch X., et al. Therapeutic approach to IgG4-related disease. Medicine (United States). 2016;95(26),e4002. doi:10.1097/MD.0000000000004002.; Ali A.H., Bi Y., Machicado J.D., et al. The long-term outcomes of patients with immunoglobulin G4-related sclerosing cholangitis: the Mayo Clinic experience. J Gastroenterol. 2020;55:1087–1097. doi:10.1007/s00535-020-01714-7.; Zen Y., Nakanuma Y., Portmann B. Immunoglobulin G4-related sclerosing cholangitis: Pathologic features and histologic mimics. Semin Diagn Pathol. 2012;29:205–211. doi:10.1053/j.semdp.2012.07.005; Stathopoulos G., Nourmand A.D., Blackstone M., et al. Rapidly progressive sclerosing cholangitis following surgical treatment of pancreatic pseudotumor. J Clin Gastroenterol. 1995;21(2):143-148. doi:10.1097/00004836-199509000-00016.; https://www.medarhive.ru/jour/article/view/1748Test

الإتاحة: https://doi.org/10.20514/2226-6704-2024-14-2-96-107Test
https://doi.org/10.1155/2021/1959832Test
https://doi.org/10.1016/S0140-6736Test(14)60720-0
https://doi.org/10.1177/2050640620934911Test
https://doi.org/10.1038/s41395-018-0036-5Test
https://doi.org/10.1002/jhbp.957Test
https://doi.org/10.1111/j.1443-1661.2010.01039.xTest
https://doi.org/10.1038/ajg.2014.223Test
https://doi.org/10.1002/art.39132Test
https://doi.org/10.1002/jhbp.596Test

المؤلفون: Evolène Deslignière (8908949), Thomas Botzanowski (4723509), Hélène Diemer (1624273), Dale A. Cooper-Shepherd (11338564), Elsa Wagner-Rousset (1624276), Olivier Colas (1624279), Guillaume Béchade (2365348), Kevin Giles (2029252), Oscar Hernandez-Alba (4738647), Alain Beck (1413784), Sarah Cianférani (1530466)

مصطلحات موضوعية: Biophysics, Biochemistry, Physiology, Pharmacology, Biotechnology, Sociology, Immunology, Hematology, Biological Sciences not elsewhere classified, Chemical Sciences not elsewhere classified, peptide, non-native disulfide bridges, arrival time distributions, IgG 4, mAb developability assessment, disulfide bonds, MS, antibody, Additional Disulfide Bridge Pairing, IMS, Classical bottom-up approaches, CDR, spectrometry, trypsin digestion, cysteine residues, humanized IgG 4 mAb

العلاقة: https://figshare.com/articles/journal_contribution/High-Resolution_IMS_MS_to_Assign_Additional_Disulfide_Bridge_Pairing_in_Complementarity-Determining_Regions_of_an_IgG4_Monoclonal_Antibody/16455790Test

الإتاحة: https://doi.org/10.1021/jasms.1c00151.s001Test

المؤلفون: Virginie Doyen (6521954), Carine Truyens (349016), Hoa Nhu Thi (10954609), Hiep Tran Thi Mong (10954615), Thanh Le Chi (10954612), Frederic De Blay (11060915), Phuong Thi Ngoe Huynh (11060918), Olivier Michel (66391), Francis Corazza (777609)

مصطلحات موضوعية: Biochemistry, Microbiology, Cell Biology, Neuroscience, Biotechnology, Immunology, Cancer, Mental Health, Infectious Diseases, CCD, IgE response, helminth infection, Dpt IgE, house dust mites Background IgE, Conclusion Helminth infections, carbohydrate cross-reactive determinant, IgE component sensitization profile, Dpt IgG 4, mast cells, microarray ISAC biochips, Ho Chi Minh city

العلاقة: https://figshare.com/articles/journal_contribution/IgE_against_Der_p_1_and_Der_p2_with_ImmunoCAP_and_ISAC_/14895386Test

الإتاحة: https://doi.org/10.1371/journal.pone.0253887.s006Test

المؤلفون: Y Liu (4702669), Z Wang (81545), L Ren (11160200), Q Zeng (7355789), W Bian (11160203), Y Zhang (5998940), J Fu (7939961), D Chen (7936976), G Yu (7750973), S Zhang (5161223), Z Li (774829)

مصطلحات موضوعية: Medicine, Cell Biology, Immunology, Mental Health, Environmental Sciences not elsewhere classified, Biological Sciences not elsewhere classified, gland, immunoglobulin G 4, IgG 4, five-grade rating system, RS, Sj ögren syndrome, SS

العلاقة: https://figshare.com/articles/journal_contribution/Sonographic_findings_of_immunoglobulin_G_sub_4_sub_-related_sialadenitis_and_differences_from_Sj_gren_s_syndrome/15023369Test

الإتاحة: https://doi.org/10.6084/m9.figshare.15023369.v1Test

المؤلفون: Xinxin Han (2670916), Panpan Zhang (534098), Jieqiong Li (327149), Zheng Liu (28397), Hui Lu (12370), Xuan Luo (270185), Boju Pan (10937736), Xiaolan Lian (5319623), Xuejun Zeng (9973486), Wen Zhang (8798471), Xiaofeng Zeng (309980)

مصطلحات موضوعية: Medicine, Cell Biology, Physiology, Immunology, Developmental Biology, Cancer, Infectious Diseases, Chemical Sciences not elsewhere classified, Conclusions IgG 4-related thyroiditis, submandibular gland involvement, 2019. Patient demographics, treatment efficacy, thyroid antibodies, IgG 4-related disease, IgG 4-RD patients, IgG 4-related thyroiditis patients, Peking Union Medical College Hospital, serum IgG 4, IgG 4-related thyroiditis, IgG 4-related thyroiditis Abstract ., PUMCH, lacrimal gland involvement

العلاقة: https://figshare.com/articles/journal_contribution/Additional_file_1_of_Clinical_features_and_treatment_efficacy_for_IgG4-related_thyroiditis/15032935Test

الإتاحة: https://doi.org/10.6084/m9.figshare.15032935.v1Test

المؤلفون: Yuko Waseda (80881), Kazunori Yamada (286428), Keishi Mizuguchi (5394965), Kiyoaki Ito (4096858), Satoshi Watanabe (103008), Masahiko Zuka (5394962), Tamotsu Ishizuka (482818), Marie Malissen (282360), Bernard Malissen (39001), Mitsuhiro Kawano (739143), Shoko Matsui (739144)

مصطلحات موضوعية: Biochemistry, Medicine, Cell Biology, Pharmacology, Immunology, Infectious Diseases, Biological Sciences not elsewhere classified, Chemical Sciences not elsewhere classified, WT, broncho-alveolar lavage fluid, LAT Y 136F knock-in mice display, broncho-vascular bundles, serum IgG 1 levels, LAT Y 136F knock-in mice, growth factor -β, G 4-related disease, IgG 4-related lung disease Rational., 10 weeks, serum IgG 4 concentration, Y 136F knock-in mice show Th 2-domi., BALF, LAT group, Methods Lung tissue samples, IgG 4-positive plasma cells, IgG 4-RD, Conclusions LAT Y 136F knock-in mice, Th 2-dominant cytokines, lung lesions, IgG 4-related lung disease

العلاقة: https://figshare.com/articles/journal_contribution/S1_File_-/14162522Test

الإتاحة: https://doi.org/10.1371/journal.pone.0247173.s001Test

المؤلفون: Kunkun Wang (5439212), Zhenfan Wang (10164058), Qiaozhu Zeng (10164061), Lijuan Zhu (1315161), Jingyuan Gao (1754260), Ziqiao Wang (6730244), Shanshan Zhang (50616), Fei Yang (46361), Danhua Shen (10127814), Yi Wang (32470), Yanying Liu (638666)

مصطلحات موضوعية: Medicine, Cell Biology, Ecology, Immunology, Cancer, Science Policy, Infectious Diseases, Biological Sciences not elsewhere classified, IgG 4-related RPF, organ involvement, IRPF group, serum IgG 4 level, IgG 4-related RPF patients, IgG 4-related retroperitoneal fibrosis, IgG 4-related RPF group, idiopathic retroperitoneal fibrosis., 132 RPF patients

العلاقة: https://figshare.com/articles/journal_contribution/STROBE_statement_Checklist_of_items_that_should_be_included_in_reports_of_observational_studies_/14055730Test

الإتاحة: https://doi.org/10.1371/journal.pone.0245601.s002Test

المؤلفون: Rodriguez-Dominguez, Azahara, Berings, Margot, Rohrbach, Alexander, Huang, Huey-Jy, Curin, Mirela, Gevaert, Philippe, Matricardi, Paolo M., Valenta, Rudolf, Vrtala, Susanne

المصدر: JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY ; ISSN: 0091-6749 ; ISSN: 1097-6825

مصطلحات موضوعية: Medicine and Health Sciences, HOUSE-DUST MITE, FC-GAMMA-RIIB, IGE REACTIVITY PROFILES, GRASS-POLLEN, ALLERGEN, SUBCUTANEOUS IMMUNOTHERAPY, IMMUNOLOGICAL MECHANISMS, CLINICAL-EFFICACY, DOUBLE-BLIND, P 23, RECOMBINANT, House dust mite, immunotherapy, recombinant allergens, basophil, activation, IgE, IgG, IgG(1), IgG(2), IgG(3), IgG(4), IgG subclass, allergen microarray

وصف الملف: application/pdf

العلاقة: https://biblio.ugent.be/publication/8683998Test; http://hdl.handle.net/1854/LU-8683998Test; http://dx.doi.org/10.1016/j.jaci.2020.03.029Test; https://biblio.ugent.be/publication/8683998/file/8686855Test

الإتاحة: https://doi.org/10.1016/j.jaci.2020.03.029Test
https://biblio.ugent.be/publication/8683998Test
http://hdl.handle.net/1854/LU-8683998Test
https://biblio.ugent.be/publication/8683998/file/8686855Test

المؤلفون: Verena K. Köhler, Silvia Crescioli, Judit Fazekas-Singer, Heather J. Bax, Gerhard Hofer, Christina L. Pranger, Karin Hufnagl, Rodolfo Bianchini, Sabine Flicker, Walter Keller, Sophia N. Karagiannis, Erika Jensen-Jarolim

المصدر: International Journal of Molecular Sciences; Volume 21; Issue 16; Pages: 5693

مصطلحات موضوعية: allergy, IgE, IgG 1, IgG 4, FcεRI, CD23, antibodies, blocking antibodies, in vitro, allergen immunotherapy

جغرافية الموضوع: agris

وصف الملف: application/pdf

العلاقة: Molecular Immunology; https://dx.doi.org/10.3390/ijms21165693Test

الإتاحة: https://doi.org/10.3390/ijms21165693Test

المؤلفون: Shamji, MH, Kappen, J, Abubakar-Waziri, H, Zhang, J, Steveling, E, Watchman, S, Kouser, L, Eifan, A, Switzer, A, Varrichi, G, Marone, G, Couto-Francisco, NC, Calderon, M, Durham, SR

المساهمون: Medical Research Council (MRC)

المصدر: 1076 ; 1067

مصطلحات موضوعية: Biomarkers of allergen immunotherapy, IgA(1), IgA(2), IgE-FAB, IgG(4), Subcutaneous immunotherapy, allergic rhinoconjunctivitis with and without asthma, blocking antibodies, Science & Technology, Life Sciences & Biomedicine, Allergy, Immunology, IgE-facilitated allergen binding, REGULATORY B-CELLS, QUALITY-OF-LIFE, CLINICAL-EFFICACY, BINDING, VACCINATION, INHIBITION, ASTHMA, RHINOCONJUNCTIVITIS, VALIDATION, ACTIVATION, Adult, Allergens, Antibodies, Neutralizing, B-Lymphocytes, Regulatory, Biomarkers

جغرافية الموضوع: United States

العلاقة: Journal of Allergy and Clinical Immunology; http://hdl.handle.net/10044/1/65397Test; G0601303; G1000758

الإتاحة: https://doi.org/10.1016/j.jaci.2018.09.039Test
http://hdl.handle.net/10044/1/65397Test